U.K.-based pharmaceutical giant AstraZeneca (NASDAQ: AZN) is making news, but not in a good way. Its operations in China were recently rocked when Leon Wang, the company's president in the country ...

These developments come at a crucial time for AstraZeneca's Chinese operations, though the company maintains its commitment to this key market. The pharmaceutical giant's swift response demonstrates ...

AstraZeneca PLC (LSE/STO/NASDAQ: LON:AZN), a leading biopharmaceutical company with a market capitalization of $206.73 billion, today announced the appointment of Rene Haas and Birgit Conix as Non ...

In recent months, the CEO of $205 billion drug giant AstraZeneca (AZN.L), opens new tab has seen his China boss detained by Beijing and his shares underperform rivals. Yet the value which ...